Background: The anti-inflammatory drug diacetyl rhein has been found to possess promising antistaphylococcal effects against various drug-resistant strains in our previous study. In the present work, we explored the in vitro combinatory interactions of diacetyl rhein with oxacillin and tetracycline against 13 standard strains and clinical isolates of Staphylococcus aureus, including those resistant to erythromycin, methicillin and tetracycline. Methods: Minimum inhibitory concentrations were determined by broth microdilution assay, and the effects of combinations were evaluated according to the sum of fractional inhibitory concentrations (ΣFICs). Results: Synergistic or additive effects were observed against all S. aureus strains (ΣFIC 0.258-1), whereas diacetyl rhein-oxacillin appeared to be the most effective combination, synergistically inhibiting the growth of 4 strains tested. Conclusion: To our best knowledge, this is the first report on a synergistic antibacterial effect of diacetyl rhein. Our results suggest this promising compound for further evaluation of its synergistic anti-infective potential as an agent with a combined anti-inflammatory and synergistic antibacterial action.

1.
Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzei T, Peters G: New insights into methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents 2012;39:96-104.
2.
Fiolic Z, Bosnjak Z, Snajdar I, Gregorek AC, Kalenic S, Budimir A: The screening of methicillin-resistant Staphylococcus aureus in vascular surgery patients: a comparison of molecular testing and broth-enriched culture. Chemotherapy 2012;58:330-336.
3.
French GL: The continuing crisis in antibiotic resistance. Int J Antimicrob Agents 2010;36:S3-S7.
4.
Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia G, Esposito S, French G, Giamarellou H, Gyssens IC, Nathwani D, Unal D, Voss A: A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin Microbiol Infect 2010;16:3-30.
5.
Kaplan SL: Recent lessons for the management of bone and joint infections. J Infect 2014;68:S51-S56.
6.
Moellering RC Jr: Discovering new antimicrobial agents. Int J Antimicrob Agents 2011;37:2-9.
7.
Dosler S, Gerceker AA: In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Chemotherapy 2011;57:511-516.
8.
Gibbons S: Phytochemicals for bacterial resistance - strengths, weaknesses and opportunities. Planta Med 2008;74:594-602.
9.
Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, Molnar J, Martins M, Amaral L: Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium. Int J Antimicrob Agents 2007;30:242-249.
10.
Mazumdar K, Dastidar SG, Park JH, Dutta NK: The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target. Eur J Clin Microbiol Infect Dis 2009;28:881-891.
11.
Zhou Y, Wang G, Li Y, Liu Y, Song Y, Zheng W, Zhang N, Hu X, Yan S, Jia J: In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis. Antimicrob Agents Chemother 2012;56:3250-3260.
12.
Shepherd WF, Fsadni MG, Raj PS: A clinical evaluation of diclofenac-gentamicin combination eye drops in the control of inflammation after cataract surgery. Diclofenac-Gentamicin versus Gentamicin Study Group. Ocul Immunol Inflamm 1998;6:13-18.
13.
Fidelix TSA, Macedo CR, Maxwell LJ, Trevisani VFM: Diacerein for osteoarthritis. Cochrane Database Syst Rev 2014;2:CD005117.
14.
Bruneton J: Quinones. Pharmacognosy, Phytochemistry, Medicinal Plants, ed 2. Paris, Lavoisier, 1999, pp 409-444.
15.
Lemli J, Lemmens L: Metabolism of sennosides and rhein in the rat. Pharmacology 1980;20:50-57.
16.
Martel-Pelletier J, Pelletier JP: Effects of diacerein at the molecular level in the osteoarthritis disease process. Ther Adv Musculoskelet Dis 2010;2:95-104.
17.
Nguon S, Novakova J, Kokoska L: In vitro antimicrobial effect of diacetyl rhein (abstract). 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, September 2012, p 177, F-1532.
18.
Joung DK, Joung H, Yang DW, Kwon DY, Choi JG, Woo S, Shin DY, Kweon OH, Kweon KT, Shin DW: Synergistic effect of rhein in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. Exp Ther Med 2012;3:608-612.
19.
Nguon S, Novy P, Kokoska L: In vitro combinatory interactions of diacetyl rhein with erythromycin, oxacillin and tetracycline against Staphylococcus aureus (abstract). V International Conference on Environmental, Industrial and Applied Microbiology (BioMicroWorld 2013), Madrid, October 2013, p 467, T47.
20.
Jorgensen JH, Turnidge JD, Washington JA: Antibacterial susceptibility tests: dilution and disk diffusion methods; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds): Manual of Clinical Microbiology, ed 7. Washington, ASM Press, 1999, pp 1526-1543.
21.
Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, ed 8. Document M7-A8. Wayne, CLSI, 2009.
22.
European Committee for Antimicrobial Susceptibility Testing: Terminology relating to methods for determination of susceptibility bacteria to antimicrobial agents. Clin Microbiol Infect 2000;6:503-508.
23.
Tegos G, Stermitz FR, Lomovskaya O, Lewis K: Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother 2002;46:3133-3141.
24.
Handzlik J, Matys A, Kieć-Kononowicz K: Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus. Antibiotics 2013;2:28-45.
25.
Kourtesi C, Ball AR, Huang YY, Jachak SM, Vera DM, Khondkar P, Gibbons S, Hamblin MR, Tegos GP: Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J 2013;7:34-52.
26.
García-Arias M, Balsa A, Mola EM: Septic arthritis. Best Pract Res Clin Rheumatol 2011;25:407-421.
27.
Song X, Cogen J, Singh N: Incidence of methicillin-resistant Staphylococcus aureus infection in a children's hospital in the Washington metropolitan area of the United States, 2003-2010. Emerg Microbes Infect 2013;2:e69.
28.
Geipel U: Pathogenic organisms in hip joint infections. Int J Med Sci 2009;6:234-240.
29.
Berberian G, Firpo V, Soto A, Mañan JL, Torroija C, Castro G, Polanuer P, Espinola C, Piñeiro JL, Rosanova MT: Osteoarthritis in the neonate: risk factors and outcome. Braz J Infect Dis 2010;14:413-418.
30.
European Medicines Agency: CMDh endorses recommendations to restrict the use of diacerein-containing medicines. London, European Medicines Agency, 2014, 162540.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.